查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602767

动物疫苗市场：依产品类型 - 2025-2030 年全球预测

Animal Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Animal Type (Aqua, Companion, Poultry) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物疫苗市值为163.9亿美元，预计2024年将达到177.5亿美元，复合年增长率为8.34%，到2030年将达到287.2亿美元。

兽用疫苗市场包括各种为预防和控製家畜、家畜和野生动物疾病而开发的免疫产品。这些疫苗对于保护动物健康、提高农业生产力和减少通用感染疾病向人类的传播至关重要。应用范围从宠物的常规疫苗接种到牛、家禽、猪等牲畜的大规模疫苗接种，具体的最终用户包括兽医医院、诊所、农场和研究机构。宠物主人数量的增加、动物性食品消费量的增加以及动物健康意识的增强推动了市场的成长。此外，世界对通用感染疾病爆发的日益关注凸显了严格疫苗接种计画的重要性。重组 DNA 疫苗和奈米颗粒递送系统等技术进步为创新提供了重要机会。透过投资研发，公司可以利用这些进步，开发出以更少剂量提供更广泛保护的疫苗。然而，市场开拓面临许多挑战，包括严格的法律规范、高昂的开发成本以及新兴国家的疫苗储存和分配问题。透过与政府机构合作并利用人工智慧主导的分析来简化核准流程，可以透过解决这些障碍来提高市场渗透率。还有机会开发针对多种病原体提供交叉保护的疫苗，并探索口服和鼻腔给药方法以提高依从性和给药便利性。我们对个人化兽医医学和资料分析的关注使我们能够根据当地疾病流行情况和动物人口统计数据提供量身定制的疫苗接种计划，从而推动市场成长。为了保持竞争力，公司应优先考虑创新、策略联盟和拓展新兴市场，以及开展教育工作以提高人们对疫苗接种益处的认识。总之，在技术进步和对动物健康日益关注的推动下，兽用疫苗市场有望持续成长，但要充分发挥其潜力，还需要克服各种障碍。

主要市场统计
基准年[2023] 163.9亿美元
预测年份 [2024] 177.5亿美元
预测年份 [2030] 287.2亿美元
复合年增长率（%） 8.34%

市场动态：揭示快速发展的兽用疫苗市场的关键市场洞察

供需的动态交互作用正在改变动物疫苗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 牲畜数量增加
    • 由于畜产品商业化，畜牧业增加
    • 通用感染疾病增加
  • 市场限制因素
    • 供应成本相对较高，资本收益低于人用疫苗
  • 市场机会
    • 从活病毒疫苗转向 DNA 疫苗
    • 疫苗技术不断进步
  • 市场问题
    • 疫苗的不良反应

波特五力：驾驭动物疫苗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解兽用疫苗市场的外部影响

外部宏观环境因素对兽用疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解动物疫苗市场竞争格局

对兽用疫苗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：兽用疫苗市场供应商的绩效评估

FPNV定位矩阵是评估兽用疫苗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划动物疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对动物疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 牲畜增加
      • 畜牧业发展及畜产品商品化
      • 通用感染疾病发生率增加
    • 抑制因素
      • 供应成本相对较高，资本收益低于人用疫苗
    • 机会
      • 从减毒活疫苗到 DNA 疫苗的过渡
      • 疫苗技术不断进步
    • 任务
      • 疫苗副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章动物疫苗市场：副产品

  • 介绍
  • 减毒活病毒疫苗
  • DNA疫苗
  • 灭活疫苗
  • 重组疫苗
  • 次单位疫苗

第七章动物疫苗市场：依动物类型

  • 介绍
  • 水生动物
    • 产气单胞菌
    • 链球菌
    • 弧菌
  • 伴同性
    • 狗
      • 狗狗疱疹
      • 犬瘟热
      • 犬窝咳
      • 莱姆病
      • 细小病毒
      • 狂犬病狗
    • 猫
      • 杯状病毒
      • 冠状病毒猫
      • 全白血球减少症
      • 狂犬病猫
      • 鼻气管炎
  • 家禽
    • 禽流感
    • 传染性支气管炎
    • 马立克氏症
    • 新城疫
    • 沙门氏菌
  • 反刍动物
    • 冠状病毒反刍动物
    • 大肠桿菌
    • 手足口病 (FMD)
    • 块状皮肤病
    • 轮状病毒

第八章美洲动物疫苗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太动物疫苗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲动物疫苗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Anicon Labor GmbH by SAN Group
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dalan Animal Health.
  • Eli Lilly and Company
  • Endovac Animal Health, LLC
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA, SA
  • Indian Immunologicals Limited
  • Merck KGaA
  • Neogen Corporation
  • Pfizer Inc.
  • Phibro Animal Health Corporation
  • Sanofi SA
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetigenics
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.
Product Code: MRR-ED54C46E8F03

The Animal Vaccines Market was valued at USD 16.39 billion in 2023, expected to reach USD 17.75 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 28.72 billion by 2030.

The animal vaccines market encompasses various immunological products developed to prevent and control diseases in domesticated animals, livestock, and wildlife. These vaccines are crucial for safeguarding animal health, improving agricultural productivity, and reducing the transmission of zoonotic diseases to humans. Their applications range from routine immunizations in pets to large-scale inoculations in livestock like cattle, poultry, and pigs, with specific end-users comprising veterinary hospitals, clinics, farms, and research institutions. Market growth is fueled by rising pet ownership, increased consumption of animal-derived food products, and heightened awareness of animal health. Moreover, growing global concerns about zoonotic disease outbreaks have highlighted the significance of rigorous vaccination programs. Technological advancements, such as recombinant DNA vaccines and nanoparticle-based delivery systems, present vast opportunities for innovation. Companies can leverage these advancements by investing in R&D to develop vaccines offering broader protection with fewer doses. However, market expansion faces several challenges, including stringent regulatory frameworks, high development costs, and vaccine storage and distribution issues in developing regions. Addressing these barriers by partnering with government agencies and harnessing AI-driven analytics for streamlined approval processes can enhance market penetration. Opportunities also lie in developing vaccines that provide cross-protection against multiple pathogens, as well as exploring oral and intranasal delivery methods to improve compliance and ease of administration. Focusing on personalized veterinary medicine and data analytics can provide tailored vaccination programs based on regional disease prevalence and animal demographics, fostering market growth. To remain competitive, companies should prioritize technological innovation, strategic alliances, and expansion into emerging markets, coupled with educational initiatives to raise awareness about the benefits of vaccination. In summary, the animal vaccines market is poised for sustained growth, driven by technological advancements and a growing emphasis on animal health, though it must navigate various regulatory and logistical hurdles to maximize potential.

KEY MARKET STATISTICS
Base Year [2023] USD 16.39 billion
Estimated Year [2024] USD 17.75 billion
Forecast Year [2030] USD 28.72 billion
CAGR (%) 8.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Vaccines Market

The Animal Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Livestock Population
    • Rising Animal Husbandry along with Commercialization of Animal Products
    • Increasing Incidences of Zoonotic Diseases
  • Market Restraints
    • Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
  • Market Opportunities
    • Shift from Live Attenuated Vaccines to DNA Vaccines
    • Continuous Technological Advancements in Vaccines
  • Market Challenges
    • Adverse Impacts of Vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Animal Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Vaccines Market

A detailed market share analysis in the Animal Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Vaccines Market

A strategic analysis of the Animal Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd., Dalan Animal Health., Eli Lilly and Company, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., Indian Immunologicals Limited, Merck KGaA, Neogen Corporation, Pfizer Inc., Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc., Vaxxinova GmbH, VEROVACCiNES GmbH, Vetigenics, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.
  • Based on Animal Type, market is studied across Aqua, Companion, Poultry, and Ruminants. The Aqua is further studied across Aeromonas, Streptococcosis, and Vibrio. The Companion is further studied across Canine and Feline. The Canine is further studied across Canine Herpes, Distemper, Kennel Cough, Lyme Disease, Parvovirus, and Rabies Canine. The Feline is further studied across Calicivirus, Coronavirus Feline, Panleukopenia, Rabies Feline, and Rhinotracheitis. The Poultry is further studied across Avian Influenza, Infectious Bronchitis, Marek's Disease, Newcastle Disease, and Salmonella. The Ruminants is further studied across Coronavirus Ruminants, E. Coli, Foot & mouth disease (FMD), Lumpy skin, and Rotavirus.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Livestock Population
      • 5.1.1.2. Rising Animal Husbandry along with Commercialization of Animal Products
      • 5.1.1.3. Increasing Incidences of Zoonotic Diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from Live Attenuated Vaccines to DNA Vaccines
      • 5.1.3.2. Continuous Technological Advancements in Vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse Impacts of Vaccines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccines
  • 6.3. DNA Vaccines
  • 6.4. Inactivated Vaccines
  • 6.5. Recombinant Vaccines
  • 6.6. Subunit Vaccines

7. Animal Vaccines Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Aqua
    • 7.2.1. Aeromonas
    • 7.2.2. Streptococcosis
    • 7.2.3. Vibrio
  • 7.3. Companion
    • 7.3.1. Canine
      • 7.3.1.1. Canine Herpes
      • 7.3.1.2. Distemper
      • 7.3.1.3. Kennel Cough
      • 7.3.1.4. Lyme Disease
      • 7.3.1.5. Parvovirus
      • 7.3.1.6. Rabies Canine
    • 7.3.2. Feline
      • 7.3.2.1. Calicivirus
      • 7.3.2.2. Coronavirus Feline
      • 7.3.2.3. Panleukopenia
      • 7.3.2.4. Rabies Feline
      • 7.3.2.5. Rhinotracheitis
  • 7.4. Poultry
    • 7.4.1. Avian Influenza
    • 7.4.2. Infectious Bronchitis
    • 7.4.3. Marek's Disease
    • 7.4.4. Newcastle Disease
    • 7.4.5. Salmonella
  • 7.5. Ruminants
    • 7.5.1. Coronavirus Ruminants
    • 7.5.2. E. Coli
    • 7.5.3. Foot & mouth disease (FMD)
    • 7.5.4. Lumpy skin
    • 7.5.5. Rotavirus

8. Americas Animal Vaccines Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Vaccines Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Vaccines Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anicon Labor GmbH by SAN Group
  • 2. Biogenesis Bago S.A.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Brilliant Bio Pharma Private limited
  • 5. Ceva Sante Animale
  • 6. China Animal Husbandry Industry Co., Ltd.
  • 7. Dalan Animal Health.
  • 8. Eli Lilly and Company
  • 9. Endovac Animal Health, LLC
  • 10. Heska Corporation
  • 11. Hester Biosciences Limited
  • 12. HIPRA, S.A.
  • 13. Indian Immunologicals Limited
  • 14. Merck KGaA
  • 15. Neogen Corporation
  • 16. Pfizer Inc.
  • 17. Phibro Animal Health Corporation
  • 18. Sanofi S.A.
  • 19. Torigen Pharmaceuticals Inc.
  • 20. Vaxxinova GmbH
  • 21. VEROVACCiNES GmbH
  • 22. Vetigenics
  • 23. Vetoquinol SA
  • 24. Virbac, Inc.
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 221. DENMARK ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 229. EGYPT ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 237. FINLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 245. FRANCE ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 253. GERMANY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 261. ISRAEL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 269. ITALY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 285. NIGERIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 290. NORWAY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 291. NORWAY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 292. NORWAY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 293. NORWAY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 297. POLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 298. POLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 299. POLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 300. POLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 301. POLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 305. QATAR ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 306. QATAR ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 307. QATAR ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 308. QATAR ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 309. QATAR ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 313. RUSSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 314. RUSSIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 315. RUSSIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 316. RUSSIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 317. RUSSIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 322. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 324. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 330. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 332. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 337. SPAIN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 338. SPAIN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 339. SPAIN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 340. SPAIN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 341. SPAIN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 343. SWEDEN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. SWEDEN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 345. SWEDEN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 346. SWEDEN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 347. SWEDEN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 348. SWEDEN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 349. SWEDEN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 354. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 356. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 358. TURKEY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 359. TURKEY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 360. TURKEY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 361. TURKEY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 362. TURKEY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 363. TURKEY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 364. TURKEY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 365. TURKEY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 369. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 370. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 371. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 372. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 373. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 374. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 375. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 376. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 377. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 378. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 379. UNITED KINGDOM ANIMAL V